MAGI2 enhances the sensitivity of BEL-7404 human hepatocellular carcinoma cells to staurosporine-induced apoptosis by increasing PTEN stability

International Journal of Molecular Medicine

Volumn 32, Issue 2, 2013, Pages 439-447

  Li, Xin ^a   Li, Zengxia ^a,c   Li, Na ^a   Qi, Jingjing ^a   Fan, Kun ^a   Yin, Peng ^a   Zhao, Chao ^a   Liu, Yonglei ^a   Yao, Wantong ^a   Cai, Xiumei ^a,c   Wang, Liying ^a,b,c   Zha, Xiliang ^a,c  

^a FUDAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

AKT; Apoptosis; Membrane associated guanylate kinase inverted 2; Phosphatase and tensin homologue; Staurosporine

Indexed keywords

GUANYLATE KINASE; LIPOCORTIN 5; MEMBRANE ASSOCIATED GUANYLATE KINASE INVERTED 2 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STAUROSPORINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; SENSITIVITY ANALYSIS;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ENZYME STABILITY; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYC; PTEN PHOSPHOHYDROLASE; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; STAUROSPORINE; TIME FACTORS; TRANSFECTION;

EID: 84879383946     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1411     Document Type: Article

References (40)

1. Pawson T and Scott JD: Signaling through scaffold, anchoring, and adaptor proteins. Science 278: 2075-2080, 1997. (Pubitemid 28028310)
2. Burack WR and Shaw AS: Signal transduction: Hanging on a scaffold. Curr Opin Cell Biol 12: 211-216, 2000. (Pubitemid 30142568)
3. Xu J, Paquet M, Lau AG, Wood JD, Ross CA and Hall RA: β1-adrenergic receptor association with the synaptic scaffolding protein membrane associated guanylate kinase inverted-2 (MAGI2). Differential regulation of receptor internalization by MAGI2 and PSD-95. J Biol Chem 76: 41310-41317, 2001.
4. Deng F, Price MG, Davis CF, Mori M and Burgess DL: Stargazin and other transmembrane AMPA receptor regulating proteins interact with synaptic scaffolding protein MAGI2 in brain. J Neurosci 26: 7875-7884, 2006. (Pubitemid 44315157)
5. Hu Y, Li Z, Guo L, et al: MAGI2 inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells. Arch Biochem Biophys 467: 1-9, 2007. (Pubitemid 47625295)
6. Hirao K, Hata Y, Ide N, et al: A novel multiple PDZ domain-containing molecule interacting with N-methyl-D-aspartate receptors and neuronal cell adhesion proteins. J Biol Chem 273: 21105-21110, 1998. (Pubitemid 28385397)
7. Wood JD, Yuan J, Margolis RL, et al: Atrophin-1, the DRPLA gene product, interacts with two families of WW domaincontaining proteins. Mol Cell Neurosci 11: 149-160, 1998. (Pubitemid 28298386)
8. Nishimura W, Yao I, Iida J, Tanaka N and Hata Y: Interaction of synaptic scaffolding molecule and β-catenin. J Neurosci 22: 757-765, 2002. (Pubitemid 34141756)
9. Ide N, Hata Y, Deguchi M, Hirao K, Yao I and Takai Y: Interaction of S-SCAM with neural plakophilin-related Armadillo-repeat protein/delta-catenin. Biochem Biophys Res Commun 256: 456-461, 1999. (Pubitemid 29301127)
10. Yao I, Hata Y, Ide N, et al: MAGUIN, a novel neuronal membrane-associated guanylate kinase-interacting protein. J Biol Chem 274: 11889-11896, 1999.
11. Wu X, Hepner K, Castelino-Prabhu S, et al: Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI2. Proc Natl Acad Sci USA 97: 4233-4238, 2000. (Pubitemid 30226116)
12. Subbaiah VK, Kranjec C, Thomasm and Banks L: PDZ domains: The building blocks regulating tumorigenesis. Biochem J 439: 195-205, 2011.
13. Morais Cabral JH, Petosa C, Sutcliffe MJ, et al: Crystal structure of a PDZ domain. Nature 382: 649-652,1996.
14. Valiente M, Andrés-Pons A, Gomar B, et al: Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem 280: 28936-28943, 2005. (Pubitemid 41161339)
15. Subauste MC, Nalbant P, Adamson ED and Hahn KM: Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI2. J Biol Chem 280: 5676-5681, 2005. (Pubitemid 40280047)
16. Maehama T and Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378, 1998. (Pubitemid 28268370)
17. Simpson L and Parsons R: PTEN: Life as a tumor suppressor. Exp Cell Res 264: 29-41, 2001. (Pubitemid 32989079)
18. Haas-Kogan D, Shalev N, Wonget M, Mills G, Yount G and Stokoe D: Protein kinase B (PKB/AKT) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8: 1195-1198, 1998. (Pubitemid 28494720)
19. Li DM and Sun H: PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95: 15406-15411, 1998. (Pubitemid 29018711)
20. Wang Y, Yang H, Liu H, Huang J and Song X: Effect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: An in vitro study. BMC Cancer 9: 174, 2009.
21. Gescher A: Analogs of staurosporine: Potential anticancer drugs? Gen Pharmacol 31: 721-728, 1998. (Pubitemid 28520048)
22. Zhang Y, Yu S, Ou-Yang J, Xia D, Wang M and Li J: Effect of protein kinase C alpha, caspase-3, and survivin on apoptosis of oral cancer cells induced by staurosporine. Acta Pharmacol Sin 26: 1365-1372, 2005. (Pubitemid 41607010)
23. Fesus L, Davies PJ and Piacentini M: Apoptosis: Molecular mechanisms in programmed cell death. Eur J Cell Biol 56: 170-177, 1991.
24. Thornberry NA, Rano TA, Peterson EP, et al: A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272: 17907-17911, 1997. (Pubitemid 27306365)
25. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS and Pieper RO: AKT pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61: 6674-6678, 2001. (Pubitemid 32896484)
26. Ta HQ, Thomas KS, Schrecengost RS and Bouton AH: A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells. Cancer Res 68: 8796-8804, 2008.
27. Stambolic V, Suzuki A, de la Pompa JL, et al: Negative regulation of PKB/AKT-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998. (Pubitemid 28458022)
28. Sun H, Lesche R, Li DM, et al: PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and AKT/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96: 6199-6204, 1999. (Pubitemid 29256643)
29. Brunet A, Datta SR and Greenberg ME: Transcription-dependent and-independent control of neuronal survival by the PI3K-AKT signaling pathway. Curr Opin Neurobiol 11: 297-305, 2001. (Pubitemid 32524094)
30. Dudek H, Datta SR, Franke TF, et al: Regulation of neuronal survival by the serine-threonine protein kinase AKT. Science 275: 661-665, 1997. (Pubitemid 27061332)
31. Franke TF, Kaplan DR and Cantley LC: PI3K: Downstream AKTion blocks apoptosis. Cell 88: 435-437, 1997. (Pubitemid 27154408)
32. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J and Evan G: Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548, 1997. (Pubitemid 27074674)
33. Kulik G, Klippel A and Weber MJ: Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and AKT. Mol Cell Biol 17: 1595-1606, 1997. (Pubitemid 27097389)
34. Chen RH, Su YH, Chuang RL and Chang TY: Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/AKT-dependent pathway. Oncogene 17: 1959-1968, 1998. (Pubitemid 28488464)
35. Gibson S, Tu S, Oyer R, Anderson SM and Johnson GL: Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for AKT activation. J Biol Chem 274: 17612-17618, 1999.
36. González-Mariscal L, Betanzos A and Avila-Flores A: MAGUK proteins: Structure and role in the tight junction. Semin Cell Dev Biol 11: 315-324, 2000. (Pubitemid 32066139)
37. Lehtonen S, Ryan JJ, Kudlicka K, Iino N, Zhou H and Farquhar MG: Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and β-actinin are components of the nephrin multiprotein complex. Proc Natl Acad Sci USA 102: 9814-9819, 2005. (Pubitemid 40993650)
38. Tsunoda S, Sierralta J, Sun Y, et al: A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade. Nature 388: 243-249, 1997. (Pubitemid 27317961)
39. Tolkacheva T, Boddapati M, Sanfiz A, Tsuchida K, Kimmelman AC and Chan AM: Regulation of PTEN binding to MAGI2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res 61: 4985-4989, 2001. (Pubitemid 32681524)
40. Planchon SM, Waite KA and Eng C: The nuclear affairs of PTEN. J Cell Sci 121: 249-253, 2007. (Pubitemid 351356695)